gardenin b has been researched along with Colonic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chou, YC; Ho, CT; Li, S; Pan, MH | 1 |
| Dong, P; Guan, H; Ho, CT; Li, S; McClements, DJ; Pan, MH; Qiu, P; Xiao, H | 2 |
3 other study(ies) available for gardenin b and Colonic Neoplasms
| Article | Year |
|---|---|
Preparation and evaluation of self-microemulsifying delivery system containing 5-demethyltangeretin on inhibiting xenograft tumor growth in mice.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Chemistry, Pharmaceutical; Colonic Neoplasms; Drug Delivery Systems; Emulsions; Flavones; HT29 Cells; Humans; Limonene; Male; Mice; Oleic Acids; Particle Size; Surface-Active Agents; Xenograft Model Antitumor Assays | 2020 |
Inhibitory effects of 5-hydroxy polymethoxyflavones on colon cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Proliferation; Cell Survival; Colonic Neoplasms; Drug Screening Assays, Antitumor; Flavones; HCT116 Cells; HT29 Cells; Humans; Inhibitory Concentration 50; Necrosis; Protein Biosynthesis; Structure-Activity Relationship | 2010 |
The p53-, Bax- and p21-dependent inhibition of colon cancer cell growth by 5-hydroxy polymethoxyflavones.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Cycle; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Flavones; HCT116 Cells; Humans; Osmolar Concentration; Poly(ADP-ribose) Polymerases; Tumor Suppressor Protein p53 | 2011 |